Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Large hemopericardium and pericardial tamponade from presumed erosion of a Watchman 2.5 device 1-year postimplantation.
Journal: Proceedings (Baylor University. Medical Center)
Published: October 28, 2022
Intravenous Fluid Therapy Is Associated with a Reduced Incidence of Contrast-Induced Nephropathy but not with a Reduced Long-Term Incidence of Renal Dysfunction After Cardiac Catheterization.
Journal: Cardiovascular revascularization medicine : including molecular interventions
Published: April 30, 2019
Race, contrast-induced nephropathy and long-term outcomes after coronary and peripheral angiography and intervention.
Journal: Cardiovascular revascularization medicine : including molecular interventions
Published: April 30, 2018
Tolerability and Biological Effects of Long-Acting Octreotide in Patients With Continuous Flow Left Ventricular Assist Devices.
Journal: ASAIO journal (American Society for Artificial Internal Organs : 1992)
Published: December 07, 2016
Race and contrast-induced nephropathy in patients undergoing coronary angiography and cardiac catheterization.
Journal: International journal of cardiology
Published: June 12, 2016
Autonomic instability and asystole: Broadening the differential diagnosis of cardiac arrhythmias.
Journal: International journal of cardiology
Published: April 30, 2016
Myocardial protection from ischemia-reperfusion injury post coronary revascularization.
Journal: Expert review of cardiovascular therapy
Published: July 24, 2015
Recombinant human interleukin-1 receptor antagonist provides cardioprotection during myocardial ischemia reperfusion in the mouse.
Journal: Cardiovascular drugs and therapy
Published: April 25, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026